All News

Austedo is the first deuterated product approved by the FDA for chorea associated with Huntington’s disease.

Statin adherence observed to reduce cardiovascular events by 23.4% in patients with diabetes.

German shepherds undergo training to detect breast cancer through smell.

Combination treatment produces a complete response in mice with epithelial cancer.

Vitamin D deficiency was found to be significantly associated with an increase in atherogenic lipids and markers of early cardiovascular disease.

Combination therapy targets tumors in epithelial cancer.

A study published in the CDC’s Morbidity and Mortality Weekly Report aimed to determine whether a decline in methadone-related deaths was related to the Medicaid reimbursement policies designed to reduce methadone prescribing.

Up to 1 in 20 patients prescribed immune globulin drugs off-label.

Nearly 200,000 calls have been made to poison control centers about pediatric opioid exposure.

Toxin produced by cigarette smoke accelerates the growth of tumors.

Although statistics gathered in 2016 indicate that we've made significant progress in reaching patients with HIV, only approximately 60% of them are in active treatment.

Top news of the day from across the health care landscape.

Women over age 75 taking statins had a 33% increased risk of developing diabetes.

Top news of the day from across the healthcare landscape.

Cytomegalovirus disease coinfection without symptoms is common in people with HIV.

The FDA approved 2 supplemental new drug applications (sNDAs) for Upsher-Smith Laboratories’ Qudexy XR (topiramate) extended-release capsules.

Two pharmacy owners were convicted of operating a pill mill out of their business, Medicine Center Pharmacy, in Atlanta, Georgia.

Morphine and Ticagrelor Drug Interaction

The FDA has approved Teva’s Austedo (deutetrabenazine) tablets, previously referred to as SD-809, for chorea associated with Huntington’s disease (HD).

A recent retrospective analysis showed that nearly 75% of long-term care patients with diabetes received SSI.

Current platforms are not designed for the dynamic needs of today’s specialty pharmacy providers.

Former Pharmaceutical Technologies executive faces up to 3 years in prison.

Rates continue to decline.

Every new health care innovation causes disruption.

Osimertinib (Tagrisso) approved for metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer.

More than 96% of Prime Therapeutics members taking Harvoni cured of hepatitis C virus.

Tyrosine kinase inhibitor improves survival in patients with rare lung cancer.

Prime Therapeutics reports more than 94% of patients who completed at last 8 weeks of treatment with Harvoni were cleared of HCV.

The FlowOx system may improve patient outcomes and reduce treatment costs.

Ambitious project marks new era for pancreatic cancer patients, investigators say.